-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Aligos Therapeutics, Maintains $70 Price Target

Benzinga·03/31/2025 11:23:13
Listen to the news
HC Wainwright & Co. analyst Ed Arce reiterates Aligos Therapeutics (NASDAQ:ALGS) with a Buy and maintains $70 price target.